Overall, 140 participants (32.1%) reported lifetime use of semaglutide, tirzepatide, dulaglutide, liraglutide, or exenatide, used for either diabetes management or weight loss, while 96 (22%) reported current use
Because this market is changing quickly, and because approval and availability can differ by product, readers should rely on current prescriptions and pharmacy verification rather than social-media pricing claims
Body scars and stretch marks : Old scars often soften in color and texture over 3 to 6 months
The aim of this collaboration is to collect findings from large external biobanks, thereby accelerating the development of new drugs
In the AMY study, bothersome hot flushes rose from 8.8% before menopause to 37.3% in late perimenopause the same years many people are on a GLP-1